Status:
COMPLETED
Hydrus Microstent for Refractory Open-Angle Glaucoma
Lead Sponsor:
Ivantis, Inc.
Conditions:
Open-angle Glaucoma
Eligibility:
All Genders
45+ years
Phase:
NA
Brief Summary
The purpose of this study is to assess the safety and effectiveness of the Hydrus Microstent in patients with refractory open-angle glaucoma.
Detailed Description
Participants will attend a screening visit, a baseline visit, a surgery visit, and 8 post-operative visits (Day 1, Day 7, Month 1, Month 2, Month 3, Month 6, Month 9, Month 12), for a total individual...
Eligibility Criteria
Inclusion
- Open-angle glaucoma with optic nerve pathology;
- Best Corrected Visual Acuity of 20/80 or better in study eye;
- Refractory glaucoma;
- Other protocol-specified inclusion criteria may apply.
Exclusion
- Secondary glaucoma other than pseudoexfoliative and pigmentary glaucoma;
- Acute angle closure, chronic angle closure, or congenial, malignant, or developmental glaucoma;
- Pre-perimetric glaucoma;
- Ocular hypertension
- Shallow or flat anterior chamber;
- Other protocol-specified exclusion criteria may apply.
Key Trial Info
Start Date :
August 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 16 2022
Estimated Enrollment :
217 Patients enrolled
Trial Details
Trial ID
NCT03267134
Start Date
August 1 2017
End Date
December 16 2022
Last Update
December 14 2023
Active Locations (20)
Enter a location and click search to find clinical trials sorted by distance.
1
Vold Vision
Fayetteville, Arkansas, United States, 72704
2
Sacramento Eye Consultants
Sacramento, California, United States, 95815
3
Eye Center of Northern Colorado
Fort Collins, Colorado, United States, 80528
4
Ocala Eye
Ocala, Florida, United States, 34474